{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T10:47:51Z","timestamp":1740134871811,"version":"3.37.3"},"reference-count":10,"publisher":"American Society of Hematology","issue":"1","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,1,4]]},"DOI":"10.1182\/blood.2023022243","type":"journal-article","created":{"date-parts":[[2024,1,4]],"date-time":"2024-01-04T16:37:43Z","timestamp":1704386263000},"page":"5-7","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":0,"title":["Ibrutinib reversal of immune exhaustion in CLL"],"prefix":"10.1182","volume":"143","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6895-1967","authenticated-orcid":false,"given":"Paul","family":"Moss","sequence":"first","affiliation":[{"name":"University of Birmingham"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"234","reference":[{"issue":"1","key":"2024010416373715600_bib1","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1182\/blood.2023020554","article-title":"Ibrutinib-based therapy reinvigorates CD8+ T cells compared to chemoimmunotherapy: immune-monitoring from the E1912 trial","volume":"143","author":"Papazoglou","year":"2024","journal-title":"Blood"},{"issue":"5","key":"2024010416373715600_bib2","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1182\/blood-2015-03-567388","article-title":"Perturbation of the normal immune system in patients with CLL","volume":"126","author":"Forconi","year":"2015","journal-title":"Blood"},{"issue":"12","key":"2024010416373715600_bib3","doi-asserted-by":"crossref","first-page":"4180","DOI":"10.4049\/jimmunol.1800241","article-title":"Chronic lymphocytic leukemia-derived IL-10 suppresses antitumor immunity","volume":"200","author":"Alhakeem","year":"2018","journal-title":"J\u00a0Immunol"},{"issue":"10","key":"2024010416373715600_bib4","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1007\/s00277-016-2760-5","article-title":"Detection of non-CLL-like monoclonal B cell lymphocytosis increases dramatically in the very elderly, while detection of CLL-like populations varies by race: findings in a multiethnic population-based cohort of elderly women","volume":"95","author":"Edlefsen","year":"2016","journal-title":"Ann Hematol"},{"issue":"6","key":"2024010416373715600_bib5","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1182\/blood.2019001262","article-title":"Integrative analysis of spontaneous CLL regression highlights genetic and microenvironmental interdependency in CLL","volume":"135","author":"Kwok","year":"2020","journal-title":"Blood"},{"issue":"10","key":"2024010416373715600_bib6","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1182\/blood.2020006965","article-title":"Outcomes of COVID-19 in patients with CLL: a multicenter international experience","volume":"136","author":"Mato","year":"2020","journal-title":"Blood"},{"issue":"2","key":"2024010416373715600_bib7","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1182\/blood.2021014960","article-title":"Long-term outcomes for ibrutinib-rituximab and chemoimmunotherapy in CLL: updated results of the E1912 trial","volume":"140","author":"Shanafelt","year":"2022","journal-title":"Blood"},{"issue":"10","key":"2024010416373715600_bib8","doi-asserted-by":"crossref","first-page":"2832","DOI":"10.3389\/fimmu.2019.02832","article-title":"Long-term ibrutinib therapy reverses CD8+ T cell exhaustion in B cell chronic lymphocytic leukaemia","volume":"12","author":"Parry","year":"2019","journal-title":"Front Immunol"},{"issue":"3","key":"2024010416373715600_bib9","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1158\/1078-0432.CCR-11-2630","article-title":"Expansion of a CD8(+)PD-1(+) replicative senescence phenotype in early stage CLL patients is associated with inverted CD4:CD8 ratios and disease progression","volume":"18","author":"Nunes","year":"2012","journal-title":"Clin Cancer Res"},{"issue":"3","key":"2024010416373715600_bib10","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1182\/blood-2015-09-667675","article-title":"Fludarabine, cyclophosphamide, and rituximab treatment achieves long-term disease-free survival in IGHV-mutated chronic lymphocytic leukemia","volume":"127","author":"Thompson","year":"2016","journal-title":"Blood"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/blood\/article-pdf\/143\/1\/5\/2180055\/blood_bld-2023-022243-c-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/blood\/article-pdf\/143\/1\/5\/2180055\/blood_bld-2023-022243-c-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,4]],"date-time":"2024-01-04T16:37:49Z","timestamp":1704386269000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/143\/1\/5\/506769\/Ibrutinib-reversal-of-immune-exhaustion-in-CLL"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,4]]},"references-count":10,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1,4]]}},"URL":"https:\/\/doi.org\/10.1182\/blood.2023022243","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"type":"print","value":"0006-4971"},{"type":"electronic","value":"1528-0020"}],"subject":[],"published":{"date-parts":[[2024,1,4]]}}}